Keeps Biopharma Inc. (KOSDAQ:256940)

Keeps Biopharma Revenue

Keeps Biopharma had revenue of 40.93B KRW in the quarter ending September 30, 2025, with 29.81% growth. This brings the company's revenue in the last twelve months to 157.75B, up 25.44% year-over-year. In the year 2024, Keeps Biopharma had annual revenue of 127.58B with 38.48% growth.

• Revenue (ttm): 157.75B
• Revenue Growth: +25.44%
• P/S Ratio: 1.27
• Revenue / Employee: 1.45B
• Employees: 109
• Market Cap: 200.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	127.58B	35.45B	38.48%
Dec 31, 2023	92.13B	77.52B	530.30%
Dec 31, 2022	14.62B	10.36B	243.08%
Dec 31, 2021	4.26B	-10.96B	-72.00%
Dec 31, 2020	15.22B	1.03B	7.23%